Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025

95 companies Today

Samsung Electronics Co., Ltd.

005930.KS Q2 2026

Reported: 2026-08-01

Samsung Electronics shares fell 5.9% after earnings as investors reacted negatively to a cautious outlook and margin pressure in the DX division despite record revenue and operating profit. Rising component costs and weak profitability in the DX segment weighed on sentiment.

Key takeaways

Q2 revenue surged 28% quarter-on-quarter to KRW 171.5 trillion, driven by strong semiconductor demand and technology leadership.
Operating profit increased 56% to KRW 89.5 trillion, with an improved operating margin of 52%, boosted by a favorable currency impact of roughly KRW 3.1 trillion.
Memory shipments hit all-time highs, lifting the DS division, while System LSI faced headwinds from a weakening mobile market.
DX division sales grew year-on-year but operating profit declined due to rising component costs and lower product profitability.
Guidance remained cautious for the second half, highlighting ongoing margin pressures and macro uncertainties, particularly in DX and display segments.

Agnico Eagle Mines Limited

AEM Q2 2026

Reported: 2026-08-01

Agnico Eagle's shares inched up 0.6% following Q2 earnings as the company's results delivered broadly in line with expectations, with solid operational performance offsetting a notably cautious tone around production towards the lower end of guidance.

Key takeaways

Gold production reached 856 thousand ounces, slightly above budget for the second consecutive quarter.
Cash costs and all-in sustaining costs remained within guidance despite elevated oil prices above $100 per barrel.
Operational improvements included record mill throughput at mines representing over half of total production.
A rock movement incident at the Barnat pit introduced operational risk, pushing expected 2026 production towards the lower end of the guided 3.3-3.5 million ounce range.
The company invested over $800 million in projects and exploration, including a $600 million cash outlay to consolidate Northern Europe land packages, strengthening the long-term growth pipeline.

American Electric Power Company, Inc.

AEP Q2 2026

Reported: 2026-08-01

Shares of American Electric Power declined 1.2% following Q2 earnings as investors appeared cautious despite modest upward guidance, reflecting concerns about ongoing margin pressure and underlying headwinds in key segments.

Key takeaways

Operating earnings were $1.36 per share, totaling $742 million, down from last year due to transmission minority interest sell-off and timing-related tax impacts.
Management raised full-year 2026 guidance modestly to $6.25-$6.55 per share from $6.15-$6.45, signaling incremental confidence but not a significant acceleration.
The company secured an additional 6 gigawatts of contracted load this quarter, mostly in Texas, supporting future growth projections.
The five-year capital plan from 2026-2030 is $78 billion, roughly doubling the plan from four years ago and expected to drive an 11% CAGR in rate base.
Strategic procurement of gas-fired turbines increased total secured capacity to ~13 gigawatts through 2031, strengthening long-term growth and reliability but suggesting a heavy capital-intensive profile.

AerCap Holdings N.V.

AER Q2 2026

Reported: 2026-08-01

Shares declined 0.8% as investors appeared cautious despite solid operational execution and an increased full-year guidance, likely reflecting concerns over margin pressure from rising airline input costs and signs of moderating traffic growth in key regions.

Key takeaways

Reported adjusted EPS of $5.14 in Q2, supporting an 18% adjusted return on equity.
Generated $1.5 billion in operating cash flow, enabling $690 million in share repurchases during the quarter and over $1.4 billion year-to-date.
Completed $1.4 billion in asset sales with a 20% gain-on-sale margin, highlighting active portfolio management.
Raised full-year EPS guidance to $16.80 excluding any further asset sale gains, reflecting continued confidence despite emerging headwinds.
Noted geopolitical-driven higher airline input costs and regional variations in travel demand, with some deceleration in Middle East, Asia Pacific, and North America flight activity.

Alamos Gold Inc.

AGI Q2 2026

Reported: 2026-08-01

Shares declined 2.6% following the earnings report as investors grappled with margin pressure driven primarily by a $90 per ounce cost increase from labor inflation and cautious progress on underground ramp-up targets.

Key takeaways

Labor and contractor cost inflation added approximately $90 per ounce in operating costs, exceeding original assumptions due to elevated contractor rates and a newly implemented retention program.
Underground mining rates at Island Gold improved to 1.55 thousand tons per day in Q2, with management targeting 2,000 tons per day by year-end, though milestones remain gradual and operational gating factors persist.
There is significant exploration upside with continuous expansion of high-grade zones at Island Gold and nearby projects, yet these remain longer-term prospects.
Capital allocation remains focused on organic growth projects, including underground development at Young Davidson, Mulatos, and a $920 million mine construction at Lynn Lake, with M&A deprioritized amid current market conditions.
Despite solid cash flow generation, margin compression from inflation and cautious operational outlooks appear to weigh on near-term profitability and investor sentiment.

Antero Resources Corporation

AR Q2 2026

Reported: 2026-08-01

Antero’s shares rose modestly by 2.8% after reporting a quarter marked by significant cost reductions and margin improvement initiatives, though the market response suggests cautious optimism rather than broad enthusiasm.

Key takeaways

Adjusted EBITDA increased 57% year-over-year despite a 16% decline in Henry Hub natural gas prices, driven by scale, product diversity, and lower cash operating expenses.
A announced cost reduction initiative aims to cut cash costs by over 25% to $2 per Mcfe by year-end 2028, reflecting a strategic shift towards more balanced liquids and dry gas development and optimized sales points.
Annual margin improvements of $300 million are expected through 2028, including the ending of legacy transactions boosting cash flow by $60 million starting Q3 26, and $105 million from optimized liquids and natural gas firm transportation.
Realized C3+ liquids price was $44.26 per barrel in Q2 26, up $6.41 from a year ago, supported by rising U.S. propane and butane export levels driven by global supply shifts.
The company’s strategic positioning in Appalachia, with a strong firm transportation portfolio and NGL production, underpins confidence in securing accretive partnerships amid increasing regional natural gas demand.

BAE Systems plc

BA.L Q2 2026

Reported: 2026-08-01

The 3.7% stock increase reflects market approval of BAE Systems’ upgraded full-year guidance and robust demand, driven by strong order intake and margin expansion.

Key takeaways

Sales grew 9% on a constant currency basis, with EBIT up 11% and earnings per share rising 13% in the first half of 2026.
Free cash flow reached GBP 1.8 billion H1, fueling confidence to increase full-year free cash flow guidance to over GBP 2 billion.
Order intake hit GBP 16 billion, pushing the backlog to GBP 84 billion, supported by geopolitical-driven demand across multiple regions.
European sales surged 30%, with MBDA notably accelerating order intake to EUR 6.5 billion in six months, more than doubling prior annual levels.
The upgraded EPS guidance of 11% to 13% growth underscores the confidence in sustained top-line growth and margin expansion amid rising defense budgets globally.

BAE Systems plc

BAESY Q2 2026

Reported: 2026-08-01

The stock rallied 5.4% following results that demonstrated broad outperformance, driven by strong order intake and an upgraded full-year guidance reflecting solid growth in sales, earnings, and cash flow.

Key takeaways

Sales grew 9% on a constant currency basis in H1, with EBIT rising 11% and earnings per share up 13%.
Order intake surged to GBP 16 billion for the half, pushing the order backlog to a record GBP 84 billion, providing strong revenue visibility.
The company raised its full-year earnings per share guidance to 11%-13% growth and expects free cash flow to exceed GBP 2 billion.
European sales grew 30%, outpacing the group overall, underpinned by accelerating defense budgets and strong demand for missile systems via MBDA.
Cash generation remained robust with GBP 1.8 billion in free cash flow over the first six months, supporting strategic flexibility and shareholder returns.

two

BFLY Q2 2026

Reported: 2026-08-01

Butterfly Network's stock was largely unchanged following Q2 2026 results, reflecting a balanced mix of steady execution in Embedded partnerships and gradual software adoption without clear upside surprises.

Key takeaways

Revenue, gross margins, and adjusted EBITDA came in near the top of prior guidance; full year guidance was raised modestly.
Embedded partnerships reached a total of 11 with two new agreements, broadening applications in brain-computer interfaces and women's health wearables.
Point-of-care ultrasound (POCUS) business advanced with six new enterprise software deals for Compass AI, growing the pipeline fivefold since last year.
Provisional authorization secured to sell to the entire VA system; broader U.S. government sales opportunities are developing.
Despite management’s positive framing, the market viewed progress as incremental rather than breakthrough, leading to a flat share price reaction of +0.1%.

Biogen Inc.

BIIB Q2 2026

Reported: 2026-08-01

Biogen's shares edged up 1.1% following Q2 results, reflecting modest investor patience amid ongoing product transitions and integration efforts without a clearly differentiated catalyst.

Key takeaways

Growth portfolio now surpasses legacy MS segment, supported by faster-than-expected adoption of high-dose SPINRAZA across Japan, Europe, and the U.S.
Launch of LEQEMBI IQLIK, enabling home dosing for Alzheimer's patients, may expand patient eligibility and support longer treatment durations.
Newly acquired Apellis products, SYFOVRE and Empaveli, contributed double-digit revenue growth since consolidation in mid-May, indicating stable integration progress.
The company has multiple upcoming Phase 3 registrational trial results over the next year in lupus, antibody-mediated rejection, and Dravet syndrome providing potential future catalysts.
Early-stage pipeline rebuilding underway with three IND filings this year, supported by recent acquisitions and collaborations, positioning Biogen for longer-term growth beyond mid-2030s.

Bayerische Motoren Werke Aktiengesellschaft

BMW.DE Q2 2026

Reported: 2026-08-01

Shares declined 1.7% following the Q2 report, reflecting investor caution around the restructuring’s path to cost savings and uncertainty over near-term margin improvement, despite strategic initiatives to stabilize pricing and improve efficiency.

Key takeaways

BMW outlined a comprehensive restructuring focused on cost reduction through sales optimization, organizational simplification, supplier partnerships, and product development shifts.
Expected savings from the 8,000 headcount reduction and restructuring efforts are projected in the high three-digit million euros range but remain uncertain and likely to impact the bottom line from 2028 onward.
Management emphasizes no fundamental change in strategic direction, highlighting the open technology approach and strong product lineup as ongoing strengths.
Production capacity in China is currently adequate, with no immediate plans for additional cuts despite previous overcapacity concerns.
The company targets returning to an EBIT margin range of 8% to 10%, but the timeline and cash impact remain unclear, with most restructuring cash outflows expected in 2027.

Bristol-Myers Squibb Company

BMY Q2 2026

Reported: 2026-08-01

Shares rose 3.5% following Q2 results that showed solid sales growth from the company’s growth portfolio and an upward revision to full-year revenue and adjusted EPS guidance, signaling investor approval of the company’s execution and pipeline progress.

Key takeaways

Growth portfolio sales increased 14%, driven by 10 products attaining double-digit growth, including Reblozyl, Breyanzi, Camzyos, Opdualag, and Qvantig.
Full-year 2026 revenue and adjusted EPS guidance were raised, reflecting confidence in ongoing commercial momentum.
Key late-stage pipeline highlights include positive Phase III data for MeziKd in multiple myeloma, encouraging results from ADC programs in solid tumors, and ongoing development of multiple pivotal-readout assets.
Timing update on milvexian’s atrial fibrillation study pushed to Q1 2027 due to slower event accrual; Alzheimer’s psychosis program readouts expected in 2027 as well.
The company is preparing for the August 17 PDUFA date for iberdomide, which may launch as the first CELMoD commercial product.

Keppel Corporation Limited

BN4.SI Q2 2026

Reported: 2026-08-01

Shares declined 4.4% as investors reacted negatively to the significant net loss in the noncore portfolio driven by legacy rig impairments and related costs, which overshadowed growth in recurring income and record funds under management.

Key takeaways

Net profit reported at SGD 155 million, substantially impacted by a SGD 375 million net loss from the noncore portfolio due to impairments on legacy rigs and termination-related charges.
Recurring income rose 13% year-on-year to SGD 467 million, supported by asset management and operating platforms.
Profit from sponsor stakes and co-investments (SSCI) jumped to SGD 175 million from SGD 18 million a year earlier, highlighting growing contributions from asset co-investments.
Funds under management exceeded targets, reaching SGD 106 billion, ahead of the SGD 100 billion goal for 2026.
Free cash flow swung positive to SGD 570 million, improving financial flexibility despite ongoing challenges in the legacy rig segment.

Boston Scientific Corporation

BSX Q2 2026

Reported: 2026-08-01

Boston Scientific's shares were essentially unchanged (-0.1%) as the quarter showed steady organic sales growth and solid margins, but the market digested cautious guidance revisions driven by softness in WATCHMAN and electrophysiology (EP) segments.

Key takeaways

Q2 organic revenue grew 7%, driven by Interventional Cardiology, Endoscopy, and Neuromodulation, within prior full-year guidance range.
Adjusted EPS of $0.86 rose 15%, aided by favorable tax outcomes, and operating margin was healthy at 28.4%.
Guidance trimmed: full-year organic growth now expected at 5%-6%, below previous midpoint; adjusted EPS growth moderation reflected in narrowed $3.28-$3.32 range.
Key headwinds in WATCHMAN (clinical evidence impacting referrals) and EP (unexpected share loss in U.S.) pressured outlook; these segments weigh on near-term growth.
Restructuring plan announced to deliver $500 million in run-rate savings by 2029, aiming to offset pressures and underpin improved growth in 2028 and beyond.

British American Tobacco p.l.c.

BTI Q2 2026

Reported: 2026-08-01

The stock declined 3.8% following the earnings release as investors reacted negatively to signs of deceleration in key segments and a cautious outlook, particularly evidenced by slower growth and competitive pressures in key regions and categories.

Key takeaways

Group revenue increased 2.9% with adjusted profit from operations up 3.5%; however, growth showed signs of slowing into the second half.
New categories revenue grew 18%, led by a 66% increase in Modern Oral, but vapour growth was uneven with heated product revenue down nearly 12% due to inventory and competitive pressures.
Combustible volumes declined 4.7%, despite revenue growth of 2.1% driven by strong price/mix actions, offsetting volume declines and market exits in Cuba and Mozambique.
The U.S. delivered an 8.5% revenue increase, supported by multi-category growth and rising profit, but value share and volume share declined amid heightened competitive activity.
Management noted moderation in H2 growth due to non-recurrence of positive inventory movements and tougher year-ago comparators, reflecting a cautious outlook.

Canfor Corporation

CFP.TO Q2 2026

Reported: 2026-08-01

Canfor’s shares jumped 10.0% as lumber pricing and volumes exceeded expectations, driven by supply constraints and operational improvements, offsetting ongoing pulp sector weakness and announced mill closures.

Key takeaways

Lumber adjusted EBITDA reached $145 million in Q2, a $116 million increase from Q1, supported by higher prices and leaner inventories.
European lumber segment improved with $37 million adjusted EBITDA, reflecting better pricing, shipments, and modest log cost relief.
North American lumber results were bolstered by cost efficiencies and strong performance in the U.S. South market.
Pulp operations posted a $12 million adjusted EBITDA loss, impacted by weak global pulp markets and planned downtime.
The company announced closures of the Northwood pulp mill and three sawmills, reflecting structural pulp market challenges and declining fiber supply, with associated impairment charges expected in Q3.

Climb Global Solutions Inc. Common Stock

CLMB Q2 2026

Reported: 2026-08-01

Climb Global Solutions shares dropped 5.6% following Q2 results as investors reacted negatively to signs of deceleration in new vendor additions and modest outlook caution, overshadowing steady performance in top vendor relationships and integration progress.

Key takeaways

Added only 2 new brands out of 34 evaluated, indicating slowed expansion of the vendor line card.
Continued growth with existing top vendors, including Darktrace and Fortinet, but these gains were not enough to offset investor concerns.
Integration of Interworks progressing, maintaining local expertise while leveraging Climb’s broader infrastructure.
Investment in cloud platform development ongoing, with initial technical blueprint nearing completion.
Board strengthened with appointment of Peter Bell to support scale and strategic M&A initiatives, primarily focused on Europe.

Chipotle Mexican Grill, Inc.

CMG Q2 2026

Reported: 2026-08-01

Chipotle’s shares surged 15% post-earnings, driven by better-than-expected traction from its Recipe for Growth initiatives, notably strong transaction growth, improving throughput, and promising technology upgrades.

Key takeaways

Q2 revenue grew 9.3% to $3.3 billion, supported by positive comparable sales and transaction growth.
Sustained momentum in new and returning menu items, including Chipotle Honey Chicken and Cilantro Lime Sauce, helped drive incremental transactions.
Operational improvements such as linebacker and expo staffing reached over 70% rollout, contributing to throughput gains and max 15 performance acceleration.
Over 1,000 restaurants have installed the high-efficiency equipment package (HEEP), delivering 2–3 additional entrees in peak 15-minute periods versus enterprise average.
Investments in hospitality, team training, and digitization (including AI-enabled demand forecasting tools) are enhancing guest experience and restaurant efficiency.

Cohu, Inc.

COHU Q2 2026

Reported: 2026-08-01

Shares surged 22% post-earnings, driven by significantly stronger than expected bookings and revenue growth fueled primarily by robust demand in high performance computing and industrial segments, alongside encouraging capacity expansion plans.

Key takeaways

Q2 sales grew 38% year-over-year to $149 million, with recurring revenue representing approximately 53% of total sales.
High performance computing bookings surged 150% year-over-year, now supporting a raised fiscal 2026 revenue estimate of $100–110 million in this segment.
Industrial segment orders increased 87% year-over-year, while consumer grew 29%, mobile remained flat, and automotive declined 24%.
Semiconductor test utilization improved sequentially to 80%, suggesting a positive shift towards capex by core IDM customers.
Capacity expansion underway in Malaysia aims to double manufacturing output by year-end and further increase capacity by mid-2027 to meet growing demand.

Columbia Sportswear Company

COLM Q2 2026

Reported: 2026-08-01

Columbia Sportswear shares fell 6.6% after the quarter as investors reacted negatively to margin compression and ongoing U.S. business challenges despite international growth. The cautious outlook on accelerating U.S. brand momentum and continued discounting weighed on sentiment.

Key takeaways

Net sales growth was driven by a 9% increase in international markets, which represent over 40% of total sales.
U.S. business declined 4%, with soft traffic in brick-and-mortar DTC stores prompting higher promotional activity and margin pressure.
Gross margins missed expectations, negatively impacted by increased discounts needed to counteract inflationary pressures on consumer discretionary spending.
Operating margins and loss per share came near the midpoint of guidance, supported by one-time U.S. tariff refunds.
Management highlighted ongoing strategic refinements to the ACCELERATE plan, expecting it will take more time to shift U.S. consumer perceptions and drive sustainable growth.

Carpenter Technology Corporation

CRS Q4 2026

Reported: 2026-08-01

Carpenter Technology’s shares declined 2.1% following Q4 earnings, reflecting tempered investor enthusiasm despite solid operating income growth, as weakening energy sales and cautious structural aerospace customers signaled uneven demand and potential margin pressure ahead.

Key takeaways

Operating income reached a record $206.9 million, up 11% sequentially, driven by a strong SAO segment margin expansion to 37.8%.
Aerospace and defense sales rose 3% sequentially and 17% year-over-year, supported by higher aircraft production rates and strong engine and fastener demand.
Medical sales grew 5% sequentially but remained 30% below prior-year levels, indicating ongoing headwinds.
Energy market sales dropped 22% sequentially and 12% year-over-year, highlighting volatility and weaker demand in this key segment.
Industrial and consumer sales surged 19% sequentially, driven by semiconductor industry strength and capital investment.

DexCom, Inc.

DXCM Q2 2026

Reported: 2026-08-01

DexCom's shares gained 11.1% following Q2 earnings as strong product demand, consistent new customer growth, and positive clinical trial results for non-insulin type 2 diabetes patients clearly outpaced concerns. Investors appear encouraged by solid revenue growth and broadening commercial coverage despite limited detail on potential margin pressures or segment weaknesses. Key Takeaways:

Key takeaways

Reported 13% year-over-year revenue growth, with 12% organic growth, driven by broad global demand for DexCom CGM systems.
New customer starts remained at record levels, including a sequential increase in the US market.
Positive clinical trial results (Connect study) demonstrated a 1.6% A1C improvement in type 2 diabetes patients not on insulin, supporting reimbursement expansion.
Coverage now includes more than 7 million non-insulin type 2 diabetes patients across major US commercial PBMs.
Announced a $1 billion share repurchase plan for 2026, signaling confidence in capital allocation and underlying business stability.

Endeavour Silver Corp.

EDR.TO Q2 2026

Reported: 2026-08-01

Shares fell 1.1% after the quarter despite solid production and revenue gains, reflecting investor concerns about significant cost pressures and cautious near-term margin outlook rather than operational execution.

Key takeaways

Production increased 36% year-over-year to nearly 2 million ounces of silver and over 10,000 ounces of gold, totaling 3 million silver equivalent ounces.
Revenue rose 150% to $212 million, with mine operating earnings improving to $74 million and mine operating cash flow reaching $100 million before taxes—a 300% jump from the prior year.
All-in sustaining costs increased 47% to $37 per ounce, driven by higher royalties, purchased materials, profit sharing, and mining taxes, as well as input cost inflation from Mexican peso appreciation.
Capital expenditures accelerated, including an $18 million increase to the Kolpa 2026 budget to expedite expansion and infrastructure projects, pressuring near-term cash flow.
Management anticipates incremental cost reductions at Terronera in H2 as higher-grade zones come online and operational efficiencies improve, but full benefits are still pending.

Euronet Worldwide, Inc.

EEFT Q2 2026

Reported: 2026-08-01

Shares fell 14.7% after the quarter as investors reacted negatively to cautious forward commentary and noticeable softness in non-accelerator businesses, particularly remittances and ATM transactions, despite strong growth in digital accelerators.

Key takeaways

Digital accelerators drove 31% year-over-year revenue growth in Q2 and 35% year-to-date, supported by Ria Digital, Issuing, and Merchant Services.
Non-accelerator segments showed softness due to U.S. immigration policy impacts on remittances and 5%-8% lower U.S. to Europe airline bookings affecting ATM transaction volumes.
Management acknowledged near-term headwinds and slower volume growth in traditional businesses, tempering near-term outlook.
CoreCard platform wins with Unibanca and Upgrade demonstrated strategic value but did not offset broader segment deceleration concerns.
Returned capital to shareholders via $50 million share repurchase during the quarter, reflecting confidence in the long-term strategy despite short-term pressures.

Edison International

EIX Q2 2026

Reported: 2026-08-01

Shares declined 6.7% as investors reacted negatively to signs of deceleration in key operational metrics and cautious commentary around the future legislative framework impacting cost of capital and investment priorities.

Key takeaways

Q2 2026 core EPS came in at $1.04, with year-to-date core EPS hitting $2.97, leading management to reaffirm full-year guidance despite headwinds.
Investor concerns center on legislative uncertainty around wildfire reform, which could increase financing costs and complicate capital deployment.
SCE is advancing wildfire mitigation through expanded covered conductor deployment (800 miles to date) and targeted undergrounding (90 miles), yet execution and prioritization remain critical.
The company is leveraging enhanced wildfire risk models and AI tools to better assess and manage safety risks, reflecting growing complexity in wildfire risk management.
Although management emphasizes discipline and safety focus, the outlook is clouded by ongoing regulatory uncertainty and potential margin pressure from financing cost volatility.

EMCOR Group, Inc.

EME Q2 2026

Reported: 2026-08-01

EMCOR's stock surged 18.6% post-earnings, driven by robust organic revenue growth, record backlog (RPOs), and strong margin expansion that significantly outperformed expectations.

Key takeaways

Revenues reached $5.15 billion, up 19.8% year-over-year; organic growth stood at 19.6% excluding acquisitions and divestitures.
Operating income hit $547 million, translating to a 10.6% operating margin, supported by strong cost control and operational discipline.
Diluted EPS increased 35% to $9.06 year-over-year, signaling substantial profitability improvement.
Record RPOs totaled $17.14 billion, up 44% year-over-year and 10% sequentially, with 95% of growth coming organically, highlighting strong forward revenue visibility.
Construction segments led growth, with Electrical Construction revenues up 24% (45% increase in network/communications sector) and Mechanical Construction up 31%, both maintaining healthy margins above 12%.

Enterprise Products Partners L.P.

EPD Q2 2026

Reported: 2026-08-01

Shares declined 1.6% following the quarter, reflecting investor caution despite solid volume growth and record EBITDA, likely due to cautious comments on capital spending ramp and outlook amid volatile global energy markets. While operational execution remains strong, investors appear cautious about increased capital commitments and the impact of volatile global energy demand on future growth and returns.

Key takeaways

Reported a record $2.8 billion of EBITDA, up 17% year-over-year, with 1x distribution coverage.
Total pipeline volumes increased 8%, marine terminal volumes surged 33%, moving 14.7 million barrels per day.
Natural gas processing inlet volumes rose to 8.1 billion cubic feet per day, including a 14% increase in the Permian Basin.
Declared a 2.8% distribution increase to $0.56 per unit and repurchased $159 million of common units in the quarter.
Raised 2026 capital expenditure guidance to $2.9-$3.4 billion gross, reflecting initial investments in three new natural gas processing and fractionation plants.

Essex Property Trust, Inc.

ESS Q2 2026

Reported: 2026-08-01

Essex Property Trust shares fell 4.3% following earnings, reflecting investor disappointment with the cautious third quarter guidance and a sequential decline in core FFO per share despite an upward revision to full year outlook.

Key takeaways

Core FFO per share for Q2 beat midpoint guidance by $0.10, driven by stronger same-property NOI (+$0.05) and non-same-property NOI (+$0.03).
Same-property NOI growth forecast for full year raised to 2.8% (up 70 bps), supported by improved revenue growth (+40 bps) and lower operating expenses (mainly property tax savings).
Third quarter core FFO per share guidance set at $3.99 midpoint, down $0.09 sequentially, pressured by normal seasonal expense increases and higher controllable spending.
Operating expense increases in H2 expected to offset some of the positive momentum from revenue growth.
Balance sheet remains solid with net debt-to-EBITDA at 5.4x, $1 billion+ liquidity, and minimal near-term maturities.

National Bank of Greece S.A.

ETE.AT Q2 2026

Reported: 2026-08-01

Shares declined 1.6% following Q2 results as investors weighed decelerating loan growth momentum and margin pressures despite continued robust credit expansion and fee income gains.

Key takeaways

Performing loans expanded 13% year-on-year, driven by a 17% increase in corporate credit and 4% growth in retail loans, with strong disbursements supporting market share gains.
Net interest income (NII) rose nearly 3% quarter-on-quarter but margins remain under pressure, with net interest margin (NIM) recovering modestly to 273 basis points and guided to about 280 basis points for full-year 2026.
Fee income increased 10% in H1, supported by retail investment sales and corporate fees, reflecting steady traction despite market volatility.
Costs grew due to investments in talent, digital infrastructure, and a landmark core banking system upgrade, potentially exerting margin pressure.
Management upgraded full-year 2026 targets but the cautious tone on margin improvement and incremental loan growth likely tempered investor enthusiasm.

Exelon Corporation

EXC Q2 2026

Reported: 2026-08-01

Exelon’s shares declined 2.6% after the quarter as investors digested signs of growing grid stress and a cautious outlook on supply growth despite stable earnings and reaffirmed guidance.

Key takeaways

Reported adjusted operating earnings of $0.43 per share, consistent with expectations; full-year guidance reaffirmed at $2.81 to $2.91 per share.
Utilities maintained top-tier reliability despite an unusually severe weather environment, including 16 major weather events affecting ComEd.
Grid resilience investments and strong operational execution enabled rapid restoration after significant outages, supporting affordability and reliability.
PJM system stress intensified with record peak demand and capacity shortfalls, signaling supply constraints and rising market prices capped by FERC limits.
Management emphasized the need for new supply investment, reflecting concerns that current market mechanisms and cost discipline alone cannot ensure long-term affordability or reliability.

Fair Isaac Corporation

FICO Q3 2026

Reported: 2026-08-01

FICO's shares fell 14.7% after the Q3 earnings report as investors reacted negatively to the Software segment's poor performance, marked by a 25% decline in non-platform revenue, and cautious indications of deceleration despite growth in Scores and platform revenue.

Key takeaways

Total Q3 revenue grew 26% year-over-year to $674 million, driven primarily by a 41% increase in Scores segment revenue to $459 million.
Software segment revenue showed a mixed picture: platform revenue surged 66%, but was offset by a 25% decline in non-platform revenue, suggesting challenges in legacy or non-core offerings.
GAAP net income increased 30% to $237 million, while non-GAAP net income rose 31% to $277 million; GAAP EPS grew 41% to $10.45, non-GAAP EPS climbed 42% to $12.18.
Free cash flow for the quarter reached $370 million with aggressive capital return activities, including a record $1.96 billion in share repurchases.
Despite positive developments in credit scoring products and adoption programs, the cautious tone around software growth and sector-specific headwinds likely weighed on investor sentiment.

Flex Ltd.

FLEX Q1 2027

Reported: 2026-08-01

The stock declined 1.2% following the quarter, reflecting investor caution despite reported revenue growth and margin expansion; the market appears to be waiting for more visibility on post-spin operational execution and longer-term outlook given the ongoing transition.

Key takeaways

Revenue grew year-over-year, driven by 35% growth in the cloud and power infrastructure segment and strength in communications and industrial units.
Margins expanded across all three segments, contributing to a record adjusted EPS of $1.00.
Management emphasized long-term transformation with the planned spin-off of the cloud and power infrastructure business into SpinCo, targeting AI infrastructure.
SpinCo positioned to address substantial power, cooling, and electrical infrastructure needs behind AI data centers, a market expected to evolve over several years.
Flex will continue as a diversified manufacturing platform with exposure to healthcare and automation trends, supporting sustainable growth post-separation.

FMC Corporation

FMC Q2 2026

Reported: 2026-08-01

The stock gained 7.0% on the news that first quarter results surpassed expectations, driven by better-than-anticipated sales volume, foreign exchange benefits, and cost controls that fueled EBITDA upside.

Key takeaways

First quarter sales of $762 million came in $12 million above the midpoint of guidance, despite a 4% year-over-year decline.
Volume increased 2% with a 5% positive foreign exchange impact; FMC-branded sales grew 6% on a like-for-like basis, led by EMEA and North America herbicides and Cyazypyr.
Price declined 6%, largely due to diamide partner volumes and Rynaxypyr price repositioning as part of the post-patent strategy.
Adjusted EBITDA reached $72 million, exceeding guidance by $17 million, benefiting from favorable FX, volume, and cost improvements.
Adjusted loss per share was $0.23, $0.15 better than the midpoint of guidance, reflecting improved operational efficiency and FX gains.

Farmland Partners Inc.

FPI Q2 2026

Reported: 2026-08-01

Shares declined 1.8% as investors digested a mixed quarter marked by reduced net income and EPS despite modest growth in adjusted FFO, alongside cautious commentary on lease renewals and credit risks in the tenant base.

Key takeaways

Net income dropped to $3.1 million ($0.07/share) in Q2 2026 from $7.8 million ($0.15/share) in Q2 2025, driven mainly by a lower net gain on asset dispositions.
AFFO rose slightly to $1.7 million ($0.04/share) versus $1.3 million ($0.03/share) year-over-year for the quarter, reflecting stability in core earnings.
Revenue streams benefited from higher interest income on loans and increased oil and gas royalties, offset by lower rental income due to prior-year property sales.
Operating expenses and provisions for credit loss increased, including elevated impairment charges on a West Coast asset.
Management remains cautious on lease renewals given challenging financial conditions among tenants despite a strong tenant mix, holding back on pushing renewal discussions.

Freehold Royalties Ltd.

FRU.TO Q2 2026

Reported: 2026-08-01

Shares rose modestly by 1.8% following the quarter as Freehold Royalties posted steady production and higher commodity prices, supporting a maintained guidance range. However, the market reaction suggests results aligned with expectations without clear upside catalysts.

Key takeaways

Q2 production averaged 15,622 BOE per day, in line with guidance of 15,500–16,300 BOE/day for 2026.
Realized commodity prices improved significantly, with crude oil averaging CAD 122 per barrel and overall realized price at $69 per BOE, up from $55 per BOE in Q1.
Funds from operations rose 30% sequentially to $78 million ($0.47 per share), supported by higher prices and modest cost improvements ($6.50 per BOE).
Net debt declined $24 million to $251 million, reducing net debt to funds flow ratio to 1x, strengthening the balance sheet.
Drilling activity accelerated with 35% more gross wells drilled (300 wells), mostly oil-focused in the Permian and Canadian core areas; timing of production additions remains subject to operator completion schedules.

Federal Signal Corporation

FSS Q2 2026

Reported: 2026-08-01

Federal Signal shares rallied 11.7% post-earnings as results demonstrated notable top-line growth, margin expansion, and cash flow generation, driving investor confidence despite modest order backlog contraction.

Key takeaways

Consolidated net sales rose 19% year-over-year to $670 million, driven by 6% organic growth and particularly strong demand in the ESG segment (+20% sales, +24% orders).
Adjusted EBITDA margin improved by 60 basis points to 21.5%, reflecting gross margin expansion and controlled operating expenses.
Adjusted EPS increased 21% to $1.42, supported by higher operating income and stable tax rate dynamics.
Operating cash flow surged 89% to $113 million, enabling a $97 million debt paydown and maintaining low leverage.
Despite an overall strong quarter, backlog declined slightly from $1.08 billion to $1 billion, mainly reflecting timing in order fulfilment.

Fiverr International Ltd.

FVRR Q2 2026

Reported: 2026-08-01

Fiverr’s shares plunged 20.8% following the earnings release as investors were disappointed by ongoing deceleration in overall marketplace demand, continued margin compression driven by shifts in the transactional work base, and a cautious outlook on near-term growth amid structural transformation.

Key takeaways

Marketplace demand decelerated further in Q2 and carried into Q3, a trend attributed to evolving AI adoption diminishing low-value transactional work.
The company is executing a strategic push upmarket toward high-value projects (> $1,000 gross order value), which now represent only 15% of completed projects and are not yet sufficient to offset the decline in lower-tier business.
Clients completing projects over $1,000 grew 13% year-over-year on a trailing 12-month basis, with programming & tech (+34%) and graphics & design (+25%) showing relative strength.
Despite growth in AI-related service categories (e.g., AI user-generated content video ads +265%, AI mobile app development +92%), the overall marketplace compression weighs heavily on volumes and revenue growth.
Management emphasized financial discipline and capital allocation during this transition, signaling the ongoing patience required as the business model shifts, underscoring limited near-term margin expansion prospects.

Gestamp Automocion, S.A.

GEST.MC Q2 2026

Reported: 2026-08-01

Gestamp’s H1 results showed modest revenue growth and margin improvement despite challenging market conditions and currency headwinds, driving a positive 3.4% market reaction. The key upside was better-than-expected margin resilience supported by cost reduction initiatives and solid execution of the Phoenix Plan, underpinning confidence in full-year guidance.

Key takeaways

Revenues at constant FX rose 1.3% in H1 2026 despite a 0.9% market contraction, reflecting a 2.1 percentage point outperformance versus the light vehicle production market.
EBITDA reached EUR 651 million excluding Phoenix Plan costs, with margins improving to 11.6% in Q2 and 11.2% for H1—exceeding prior year margins despite lower volumes.
Free cash flow generation was EUR 86 million excluding Phoenix costs, maintaining solid cash flow conversion and supporting a reduction in net debt to EUR 1.77 billion.
Market weakness was concentrated in China (-5.3% production decline) and Mercosur, though Eastern Europe showed strong outperformance with over 15% EBITDA margins.
Extraordinary items impacted net profit: a EUR 15 million EV-related asset write-down and EUR 23 million positive IFRS 9 adjustment; adjusted net profit approximated EUR 104 million, representing a 40% increase year-on-year.

Huntington Ingalls Industries, Inc.

HII Q2 2026

Reported: 2026-08-01

HII’s shares surged 16.4% post-earnings, driven by raised shipbuilding revenue and margin guidance, alongside continued strong contract awards and operational throughput gains that clearly exceeded investor expectations.

Key takeaways

Q2 sales reached $3.4 billion with diluted EPS of $5.27.
Shipbuilding sales grew 16% year-over-year, marking the fourth consecutive quarter of double-digit growth.
Raised 2026 shipbuilding revenue guidance to $10.2–$10.4 billion and margin guidance to 6–6.5%.
Secured $6.7 billion in contract awards during the quarter, signaling sustained customer demand.
Operationally, throughput improved 12% year-to-date with plans for 15% full-year growth supported by over 3,500 new hires and increased distributed shipbuilding capacity.

The Hershey Company

HSY Q2 2026

Reported: 2026-08-01

Shares declined 4.8% following the earnings release, predominantly due to cautious second-half guidance and shipment timing shifts that disappointed expectations despite better-than-anticipated first-half results.

Key takeaways

Second-quarter consumer demand was understated by about 2 percentage points due to Easter timing and nonmeasured channel growth, with retail inventory replenishment adding another point of growth.
Q2 shipments included a modest pull-forward of over 1 point of Q3 merchandising, creating uneven timing that clouds visibility into the second half.
Management maintained a cautious outlook for the back half of 2026, citing tougher year-over-year comparisons and ongoing macroeconomic uncertainties despite recent strength.
Full-year guidance was only modestly raised due to the earlier-than-expected inventory replenishment and planned reinvestments behind innovation and marketing.
Long-term organic sales growth targets for 2027 remain unchanged; however, execution risks tied to category dynamics, consumer behavior, and commodity prices emphasize a need for prudence.

Excel Corporation

HXL Q2 2026

Reported: 2026-08-01

Hexcel’s shares declined 2.5% following Q2 results that showed deceleration in the Defense & Space segment and cautious outlook on industrial sales, which tempered otherwise solid commercial aerospace growth and margin expansion.

Key takeaways

Q2 sales increased 8% year-over-year to $529 million, driven primarily by an 18.3% rise in commercial aerospace sales to $346.6 million.
Adjusted operating margin improved to 13.9% from 11.1% in Q2 2025, reflecting operating leverage from higher volumes.
Commercial aerospace demand remains strong, with Airbus and Boeing production ramp-ups supporting expectations of 80 A350 shipsets in 2026.
Defense, Space & Other sales declined 7% to $182.7 million, largely due to lower industrial volumes following portfolio adjustments and divestitures.
Hexcel plans to accelerate hiring and restart carbon fiber lines to meet expected second-half demand, aiming for 18% operating margins by decade-end.

Illumina, Inc.

ILMN Q2 2026

Reported: 2026-08-01

Illumina’s shares rose 5.3% following Q2 results that surpassed expectations on multiple fronts, including revenue growth and margin performance, driven primarily by sustained strength in clinical sequencing demand and higher-than-anticipated NovaSeq X placements.

Key takeaways

Rest of world organic revenue grew 8.1%, beating the high end of guidance, with U.S.-Canada clinical markets showing particular strength.
More than 95 NovaSeq X instruments were placed in the quarter, supporting future consumable growth prospects.
Margins and EPS came in above guidance despite higher costs, reflecting disciplined expense management.
Research and academic markets remain cautious due to funding uncertainties, though signs of late-quarter improvement were noted.
Illumina raised full-year revenue and EPS guidance, expecting continued momentum in clinical consumables supported by a growing installed base and a stable outlook for 2027 growth.

Invitation Homes Inc.

INVH Q2 2026

Reported: 2026-08-01

Invitation Homes shares declined 1.3% after reporting steady but modest second quarter growth with little new impetus. The market appears cautious despite stable occupancy and modest lease rate gains, reflecting subdued margin expansion and limited visibility on near-term acceleration.

Key takeaways

Average occupancy held firm above 97%, demonstrating ongoing demand stability.
Same store NOI grew 1.5% year-over-year, driven by 1.6% core revenue growth but partially offset by 1.9% core operating expense growth.
Renewal rent growth accelerated from just over 3% early in the quarter to 3.7% in June, averaging 3.3% for Q2; new lease growth remained subdued at 1.1%.
Turnover improved 50 basis points year-over-year to 5.7%, supporting occupancy trends but potentially limiting upside to rent growth.
Share repurchases continued with $100 million bought back in Q2 at an average price above the current market price, funded largely by premium home sales, signaling capital recycling as a primary value driver.

International Paper Company

IP Q2 2026

Reported: 2026-08-01

Shares declined 4.2% as investors reacted negatively to cautious outlook signals and margin pressure implied during the quarter, despite operational progress and strategic investments.

Key takeaways

North America box volumes grew 1.7% year-over-year on a daily basis, with company expectations to outpace industry growth by approximately 2% for full year 2026.
Mill performance improved by roughly 500 basis points year-over-year, supported by cost and complexity reductions and targeted reliability investments.
Strategic 80/20 capital allocation focused on higher-return projects like NORPAC acquisition and Riverdale machine conversion, with ramp-up expected to complete by early 2027.
Temporary disruption at NORPAC linked to the neighboring Nippon facility incident was addressed swiftly; mill operations have returned to pre-incident levels.
Despite ongoing operational improvements, management’s remarks and cautious tone on outlook likely contributed to investor disappointment and margin concerns.

Ivanhoe Mines Ltd.

IVN.TO Q2 2026

Reported: 2026-08-01

Shares of Ivanhoe Mines dropped 4.9% following the earnings report, reflecting investor disappointment primarily due to a downward revision in full-year copper production guidance and a cautious outlook on near-term operational momentum despite cost controls.

Key takeaways

Copper production in Q2 exceeded 64,000 tonnes, with first half 2026 C1 cash costs averaging $2.70 per pound, toward the lower end of guidance.
Full-year 2026 copper production guidance was tightened to 290,000–310,000 tonnes, indicating a slight cut relative to prior expectations.
The Kamoa-Kakula operation undertook a turnaround strategy at Kakula, with production rates expected to increase progressively in H2, suggesting near-term operational deceleration.
Sulfuric acid sales benefitted from rising prices, with contracts increasing from $465 per tonne in Q2 to $840 per tonne in July.
Despite strong sustainability and safety initiatives, the company reported a fatality incident underground, which may affect operational continuity and risk perception.

KBR, Inc.

KBR Q2 2026

Reported: 2026-08-01

KBR's shares edged up 1.9% following Q2 results as the company delivered steady execution and maintained guidance, but the market reaction suggests investors remain cautious on growth inflection or margin expansion given ongoing separation costs and moderate book-to-bill in MTS.

Key takeaways

Total backlog reached a record $5.5 billion in the Sustainable Tech Solutions (STS) segment, up 40% year-over-year, supported by a strong 1.5x book-to-bill ratio for the quarter.
STS revenue visibility remains solid with ~80% of 2026 revenue guidance midpoint already under contract and an increasing share of durable OpEx-related contracts (34% of bookings year-to-date).
In Mission Technologies & Services (MTS), backlog seems understated due to $10.6 billion of awarded work under protest; book-to-bill was 0.8x this quarter with trailing 12-month at 1.0x.
The company reaffirmed full-year 2026 guidance, while actively managing separation costs and seeking to reduce incremental stand-alone costs ahead of spin-off.
Capital deployment totaled $261 million in H1, including $190 million of investments and $71 million returned via dividends and buybacks, reflecting disciplined allocation amid ongoing structural changes.

Kinross Gold Corporation

KGC Q2 2026

Reported: 2026-08-01

Kinross Gold's shares declined modestly by 0.5% following the Q2 earnings release, reflecting a market response that found the results largely in line with expectations without clear upside catalysts.

Key takeaways

Q2 gold production reached 492,000 ounces, driven primarily by Tasiast and Paracatu, which together contributed over half of total output.
Cost of sales was $1,336 per ounce and all-in sustaining costs totaled $1,821 per ounce, consistent with prior guidance.
Operating margins remained stable at over $3,100 per ounce, supporting strong free cash flow of $727 million after capital expenditures and taxes.
Balance sheet strengthened with a record $2.7 billion in cash and $1.9 billion in net cash by quarter end.
Returned approximately 37% of free cash flow to shareholders year-to-date via dividends and share buybacks, on track for a 40% full year target.

KKR & Co. Inc.

KKR Q2 2026

Reported: 2026-08-01

KKR shares edged up 2.2% following Q2 results that reflected steady execution in asset management and infrastructure, though the market’s modest reaction suggests a lack of clear upside catalysts or concerns over growth trajectory or margin leverage.

Key takeaways

The firm emphasized multiple secular growth drivers, including a global CapEx cycle and AI infrastructure demand, highlighting a $75 billion investment to date in digital infrastructure and power.
KKR launched Helix Digital Infrastructure with $10 billion in committed capital, targeting AI-related data center and connectivity needs, aiming to build a recurring fee base with marquee partners involved.
Asia remains a major growth focus, with a strong presence across private equity, infrastructure, real estate, and credit, and a strategic intent to capitalize on demographic shifts driving retirement investing.
Management underscored KKR’s unique culture and alignment, with roughly 30% insider ownership, supporting its long-term business model centered on earnings growth without significant headcount expansion.
Despite these positives, the share price gain below 3% implies investors are digesting the outlook and execution without clear signs of acceleration or margin improvement.

Loblaw Companies Limited

L.TO Q2 2026

Reported: 2026-08-01

Loblaw's shares declined modestly by 0.3% following a largely in-line quarter with steady revenue growth and stable margins, but without clear upside catalysts to move the stock higher.

Key takeaways

Q2 revenue rose 4.1% to $15 billion, driven by new store openings and positive same-store sales.
Adjusted EBITDA increased 5.1% to $1.9 billion, with a slight 10-basis-point improvement in margin.
Adjusted EPS grew 11.9% to $0.66, reflecting operational consistency but no surprising acceleration.
Food retail same-store sales increased 1.6%, including a 20-basis-point drag from recent store rollouts; hard discount banners led with roughly 4% comp growth.
Drug retail same-store sales growth of 4.6%, driven by a 7.5% increase in pharmacy and healthcare services, though early indications of generic GLP-1 impact remain uncertain.

Landmark Bancorp, Inc.

LARK Q2 2026

Reported: 2026-08-01

Shares declined 1.8% following Landmark Bancorp’s Q2 report as investors digested cautious commentary on deposit outflows, a modest decline in average loans, and rising nonperforming assets, tempering the quarter’s otherwise steady earnings and margin performance.

Key takeaways

Net income rose modestly to $5.4 million, up from $5.1 million in Q1, supported by higher net interest income and gains on sale of loans.
Net interest income improved slightly by $57,000 quarter-over-quarter, driven by increased yields on investments and lower funding costs, although average loans declined by $3.2 million.
Total deposits fell $17.7 million, primarily due to a $28.7 million drop in brokered deposits, partially offset by a $11.0 million increase in core deposits.
Nonperforming loans increased by $2.7 million to $13.1 million, while net charge-offs inched up to 0.17% of average loans, reflecting some emerging credit pressure.
Tangible book value per share rose to $21.76, a 16.8% annualized linked quarter increase, while the dividend was maintained at $0.21 per share marking the 100th consecutive quarterly payout.

LKQ Corporation

LKQ Q2 2026

Reported: 2026-08-01

LKQ shares fell 14.9% after the quarter as investors reacted negatively to the cautious outlook driven by Europe’s ERP implementation challenges, execution missteps, and softer demand, which overshadowed modest North American growth and margin improvements.

Key takeaways

North America returned to positive organic growth (0.5%) for the first time in nine quarters, with alternative part utilization exceeding 40%, a new record for the year.
European results were weighed down by prolonged ERP implementation issues in Germany and weaker sales in the U.K. and Benelux, disrupting service levels and revenue.
Management transitioned leadership in underperforming regions and initiated recovery plans targeting commercial execution, cost control, and customer retention.
Despite a $40 million year-over-year improvement from cost optimization and productivity in Europe, these gains failed to offset the operational disruptions and market softness.
The company emphasized long-term strategic investments expected to boost future earnings power, but near-term results and outlook fell short of investor expectations.

LPL Financial Holdings Inc.

LPLA Q2 2026

Reported: 2026-08-01

LPL Financial’s shares rose 4.7% following Q2 results that beat investor expectations, driven by improved organic growth, record recruiting activity, and progress on the Commonwealth integration.

Key takeaways

Total client assets reached $2.6 trillion, up 10% sequentially, supported by both organic net new assets of $23 billion and higher equity markets.
Organic growth accelerated to a 4% annualized pace, with recruiting assets hitting $25 billion — the strongest in nearly two years before large institutional wins.
Asset retention held steady at 97% for the quarter and over the past 12 months.
Commonwealth integration remains on track for Q4 onboarding, with current retention in the mid-80% range and initiatives underway to improve platform capabilities and adviser experience.
Continued operating leverage gains and capital deployment included acquisition of Mariner Advisor Network and accelerated share repurchases amid market dislocation.

Mid-America Apartment Communities, Inc.

MAA Q2 2026

Reported: 2026-08-01

The stock declined 3.7% following the earnings release, reflecting investor disappointment with slower-than-desired new-resident lease rate recovery amid ongoing cautious consumer sentiment and elevated supply in key markets.

Key takeaways

Core FFO results were ahead of expectations, supported by controlled operating expenses and solid demand drivers such as job growth and inbound migration.
New-resident lease rate growth improved sequentially but remains slower than management’s target due to persistent consumer caution and high new supply in concentrated markets.
Same-store operating expense growth remained modest at 80 basis points year over year, reflecting strong expense discipline.
Demand continues to outpace new supply deliveries, aiding absorption, but margin expansion remains tempered by market conditions.
Development and acquisition activity remains disciplined with four new developments planned, while portfolio recycling is ongoing, signaling cautious capital allocation amid uncertain near-term recovery pace.

Markel Corporation

MKL Q2 2026

Reported: 2026-08-01

Markel's shares dropped 6.6% following the release of disappointing results driven primarily by a significant reserve charge in the financial segment and overall flat revenue growth signaling operating deceleration. Investors also grappled with a cautious tone around potential credit losses tied to the State National business, which marked its first substantial credit loss in over 40 years.

Key takeaways

A $205 million reserve relating to a collateral shortfall at State National following a bankruptcy event materially weighed on the quarter; management framed this as a one-off but investors likely wary.
Operating revenues remained flat at $4 billion for Q2 and $7.6 billion year-to-date versus the prior year, indicating little top-line growth momentum.
The ongoing insurance business, excluding Global Re and Hagerty, reported 10% top-line growth with a combined ratio in the low 90s, showing underwriting improvement and early expense discipline.
Share repurchases accelerated to $237 million in Q2 (1% of outstanding shares), funded entirely through earnings without additional leverage.
Despite stable industrial profitability and positive underwriting trends, the market’s negative reaction suggests these positives failed to offset concerns over credit risk and near-term growth deceleration.

Altria Group, Inc.

MO Q2 2026

Reported: 2026-08-01

Shares declined 8.8% following the earnings release, primarily due to cautious outlook signals and deceleration in on! nicotine pouch shipment volumes, as trade inventory movements weighed on second-quarter results despite ongoing brand investments.

Key takeaways

on! nicotine pouch shipment volume fell 4.2% year-over-year in Q2, attributed to trade inventory adjustments, although year-to-date shipments rose 5.1%.
on! retail share reached 8.6%, improving sequentially and annually by modest margins driven by on! PLUS expansion efforts.
Helix expanded distribution of on! PLUS to 120,000 stores and plans further flavor and strength line extensions later this year.
The oral tobacco category grew approximately 6% over six months, with nicotine pouches capturing nearly 60% category share.
Regulatory progress from the FDA provides some clarity, but management emphasized continued uncertainty regarding authorization timelines and illicit product enforcement.

Modine Manufacturing Company

MOD Q1 2027

Reported: 2026-08-01

Shares jumped 12.9% as Modine’s outsized data center revenue growth and backlog expansion overshadowed near-term margin pressure from supply chain disruptions, reaffirming confidence in multi-year earnings momentum.

Key takeaways

Data center revenues surged 90% year-over-year but declined sequentially due to unexpected supply chain shortages impacting component availability and capacity utilization.
Margin compression in the data center segment reflected temporary inefficiencies in labor and overhead from production downtime; management characterized this as a transitional, not structural, issue.
The backlog hit a new high with third consecutive quarter of record order intake, underpinning strong visibility for revenue and earnings growth over the next 2-3 years.
Commercial HVAC revenues rose 22%, boosted by last year’s acquisition and increased coil sales to data center customers; strategic manufacturing consolidation and pricing actions aim to improve margins.
Performance Technologies segment progressed toward planned spin-off and merger with Gentherm, including regulatory filings and internal separation preparations.

Magnachip Semiconductor Corporation

MX Q2 2026

Reported: 2026-08-01

Shares declined 1.5% after the quarter as investors absorbed cautious tone on near-term execution and revenue growth, despite management’s strategic repositioning and partnership announcement. The market reaction signals some skepticism remains around pacing of the company’s turnaround and margin trajectory.

Key takeaways

Revenue performance was mixed with no clear acceleration, reflecting ongoing challenges in core legacy power semiconductor segments.
Margins faced pressures, consistent with the market’s muted response, as management acknowledged the commoditized nature of parts of their portfolio.
The new CEO emphasized a pivot toward differentiated, higher-value products and signaled ongoing transformation rather than immediate results.
Strategic partnership with Navitas Semiconductor was highlighted as a foundation for entering higher-voltage silicon carbide markets, but no near-term financial impact was detailed.
Guidance for Q3 was cautious, underscoring investor concerns about the timing and scale of the company’s operational turnaround.

NMI Holdings, Inc.

NMIH Q2 2026

Reported: 2026-08-01

Shares in National MI Holdings were essentially unchanged (-0.1%) following a quarter that delivered steady growth and record revenue, but showed slight persistency decline and stable yields, which neither clearly impressed nor disappointed investors.

Key takeaways

New insurance in force (NIW) volume reached $16 billion, sustaining growth momentum.
Primary insurance in force rose to a record $227.1 billion, reflecting portfolio expansion.
Adjusted net income hit a record $106 million, with earnings per share of $1.38 and 15.9% return on equity.
Net premiums earned increased to $157.5 million, up modestly quarter-over-quarter.
12-month persistency declined slightly to 81.4% from 82.2% last quarter; net and core yields remained stable.

Omega Healthcare Investors, Inc.

OHI Q2 2026

Reported: 2026-08-01

Shares declined 1.4% following Q2 results as investors reacted cautiously to flat sequential AFFO and ongoing asset sales weighing on near-term earnings, despite management’s optimism on longer-term earnings accretion from capital redeployment.

Key takeaways

Q2 AFFO was $0.83 per share, showing year-over-year growth but effectively flat sequentially due to a $563 million asset sale headwind.
Asset sales occurred at an effective 6.7% cap rate on cash flow, intended to strengthen credit support for operators and fund future accretive acquisitions.
Management signaled transaction volumes for the remainder of 2026 and into 2027 are expected to increase meaningfully.
Recent acquisitions, including the first U.K. care home operating company, are structured to deliver higher earnings accretion compared to traditional triple net deals.
While the underlying strategy targets long-term value, the flat near-term earnings and sales-related headwinds may have tempered investor enthusiasm.

L'Oreal S.A.

OR.PA Q2 2026

Reported: 2026-08-01

L’Oréal’s shares edged up modestly by 0.9% following first half results reflecting steady growth and margin stability, but without a clear catalyst to push the stock higher amid mixed signals from slowing sales acceleration and margin pressures in certain segments.

Key takeaways

Adjusted like-for-like sales growth moderated to 6.5%, continuing a gradual acceleration but lacking sharp momentum; foreign exchange remained a notable headwind with a negative 2.8% impact on sales.
Gross margin improved slightly to 74.8%, up 10 basis points, but advertising and promotional expenses rose by 70 basis points to 32.6% of sales, limiting operating margin expansion despite cost controls.
Operating margin increased 20 basis points to 21.3%, setting a new first-half record, while each division delivered margins above 22%, except for a 20 basis point dilution in the Luxe segment due to first-time consolidation effects.
Professional products showed the strongest growth at 11.6%, but makeup growth was weaker at 2.5%, hampered by service issues in the Americas.
E-commerce continued strong momentum with 18% growth, increasing its share within overall sales, while brick-and-mortar channels grew a modest 2.5%.

O'Reilly Automotive, Inc.

ORLY Q2 2026

Reported: 2026-08-01

Shares declined 1.4% following the quarter as investors appeared cautious despite solid sales and EPS growth, mostly due to a tempered second-half outlook and expected deceleration in inflation-driven price benefits.

Key takeaways

Comparable store sales increased 6% in Q2 and 7% year-to-date, driven by balanced growth in both professional (+10%) and DIY segments.
Diluted earnings per share rose 10% in Q2 and 13% for the first half of 2026, supported by profitable sales growth.
Inflation contributed a 5.5% same SKU price increase in Q2, consistent with expectations, with this benefit projected to moderate to 1-2% in the back half of the year.
Full-year comparable store sales guidance was raised to 4-6%, up from 3-5%, reflecting first-half outperformance but maintaining a cautious stance for the back half.
Management highlighted potential volatility in seasonal demand and price benefits, signaling restraint in growth assumptions despite a strong Q2.

Pharming Group N.V.

PHARM.AS Q2 2026

Reported: 2026-08-01

Shares dropped 20.1% as investors reacted negatively to the $30 million full-year revenue guidance cut, driven primarily by ongoing RUCONEST revenue decline and a cautious outlook on near-term growth despite strong Joenja expansion.

Key takeaways

Full-year revenue guidance was lowered by $30 million, reflecting weaker-than-expected RUCONEST sales amid competitive pressures and international market withdrawals.
RUCONEST revenue declined 10% year-over-year to $72.3 million, though it showed a 24% sequential increase; active patient base remains at 93% of prior-year levels.
New patient enrollments for RUCONEST rose to 84 this quarter, nearing 2025 Q2 levels, and 17 new prescribers were added, but these were insufficient to offset competitive headwinds.
Joenja revenue grew 40% year-over-year to $17.9 million, with momentum accelerating in Europe and expansion opportunities in primary immunodeficiencies beyond APDS.
Operating expenses guidance was reduced by $15 million to $315–320 million, supporting positive cash flow amid the cautious revenue outlook.

Primary Health Properties PLC

PHP.L Q2 2026

Reported: 2026-08-01

Shares fell 2.3% as investors absorbed a cautiously paced outlook and near-term leverage concerns despite steady operational execution and ongoing deleveraging progress.

Key takeaways

Adjusted EPS grew 9% to 3.8p, supported by rental growth and cost synergies from the Assura merger.
Passing rent on reviews increased 6% (3.2% annualized), buoying income stability.
Over 90% of merger-related cost synergies have been realized, driving EPRA costs below 9%.
Deleveraging remains on track with planned disposals and joint venture formation targeted to reduce bridging facility debt imminently.
Loan-to-value ratio currently elevated in the low 50s but expected to fall below 50% over time with capital recycling and valuation gains.

Impinj, Inc.

PI Q2 2026

Reported: 2026-08-01

Impinj shares surged 10.9% post-earnings, reflecting investor approval of record revenue and unit volumes that surpassed expectations across multiple end markets and product lines.

Key takeaways

Q2 revenue reached a record $108.4 million, up 46% sequentially and 11% year-over-year.
Endpoint IC product revenue beat forecasts, driven by all-time high unit volumes, notably from retail apparel, general merchandise, and supply chain/logistics.
The custom ASIC ramp at a major North American supply chain partner is ahead of schedule, supporting strong demand and expected full conversion in Q3.
Reader IC revenues exceeded expectations on strong enterprise adoption, with reader ICs projected as the fastest-growing product line next quarter.
Early traction in food-related RAIN RFID programs is promising, though current scale remains modest relative to supply chain and general merchandise markets.

Q2 Holdings, Inc.

QTWO Q2 2026

Reported: 2026-08-01

Q2 Holdings’ shares edged down 0.3% following Q2 results that showed steady top-line growth and healthy customer engagement but lacked clear upside catalysts to move the stock meaningfully.

Key takeaways

Revenue reached $219.8 million, up 13% year-over-year, reflecting ongoing subscription strength.
Adjusted EBITDA was $62.8 million, or 28.6% of revenue, indicating consistent operating leverage.
Free cash flow totaled $51 million, aligning with solid cash generation.
Bookings included 8 Tier 1 and enterprise wins, driven by expansions in digital banking, risk and fraud, and relationship pricing.
Management highlighted momentum from M&A-driven deals and growing customer interest in practical AI applications, though these themes did not translate into an uplift in market sentiment.

Regeneron Pharmaceuticals, Inc.

REGN Q2 2026

Reported: 2026-08-01

Regeneron's stock rose 9.7% following a Q2 report that delivered strong top-line growth led by blockbuster product sales, notably Dupixent and EYLEA HD, which outpaced expectations and reinforced confidence in the company’s commercial momentum and pipeline potential.

Key takeaways

Total revenues grew 17% year-over-year, driven primarily by Dupixent’s global net sales of $6 billion, up 38% on a constant currency basis.
EYLEA HD U.S. net sales nearly $600 million, up 52% year-over-year, with physician demand increasing 24% sequentially, marking the first quarter EYLEA HD sales surpassed the original EYLEA.
Libtayo sales hit nearly $500 million globally, up 29% constant currency, supported by strong adoption in non-melanoma skin cancer and increased market share in non-small cell lung cancer (20% of new-to-brand U.S. prescriptions).
Management highlighted a robust, diversified pipeline with promising early clinical data on follow-on Dupixent programs and next-generation interleukin-13 antibody candidates.
Ongoing work with the FDA and partners targets year-end approval of a new EYLEA HD prefilled syringe, expected to further accelerate product adoption.

Sacyr, S.A.

SCYR.MC Q2 2026

Reported: 2026-08-01

Sacyr’s stock rose modestly by 2.8% as the company delivered steady H1 2026 results marked by solid top-line growth and improved EBITDA margins, while investors digested continued asset valuation gains and enhanced shareholder distributions.

Key takeaways

Revenue increased 9% to EUR 2.437 billion, driven by operational progress and new projects.
EBITDA grew 9% to EUR 708 million, lifting the margin to 29.1%, reflecting operational efficiencies.
Operating cash flow rose 18% to EUR 631 million on a comparable basis, underscoring strong cash generation.
Net profit attributable to shareholders surged 157% to EUR 78 million, influenced by accounting effects from prior divestments.
Concession portfolio valuation reached EUR 4.601 billion, up 16% year-on-year, supported by asset roll-forward effects and new project additions.

Shell plc

SHEL.L Q2 2026

Reported: 2026-08-01

Shell’s shares rose modestly by 1.8% following Q2 results that showed operational resilience and effective portfolio optimization, but the market reaction suggests tempered enthusiasm amid ongoing geopolitical volatility and a cautious outlook on distribution dynamics.

Key takeaways

Adjusted earnings reached $9.8 billion with over $21 billion in operating cash flow, supported by strong upstream and LNG performance despite Middle East disruptions.
LNG Canada hit full capacity this quarter and has shipped over 100 cargoes since launch, partially offsetting lost volumes from Qatar.
Refinery utilization surpassed 100%, emphasizing a successful shift toward higher-margin middle distillates like jet fuel.
Structural cost savings total $700 million in 2026, contributing to nearly $6 billion in portfolio cost reductions since 2022.
Management confirmed unchanged 2026 CapEx guidance of $24–26 billion, including $4 billion related to the ARC Resources acquisition, which awaits final regulatory approval.

Sika AG

SIKA.SW Q2 2026

Reported: 2026-08-01

Shares rose 11.3% as the company delivered accelerating local currency sales growth and expanded margins, prompting a meaningful upward revision to full-year growth guidance.

Key takeaways

Reported sales totaled CHF 5.59 billion, a slight decline, but local currency growth accelerated to 4% in H1, improving from Q1 into Q2.
Material margin expanded 60 basis points to 55.7%, reflecting operational efficiencies and price management.
Full-year local currency growth guidance was raised significantly from 1–4% to 3–6%, underpinning investor confidence.
Regional performance was broad-based: EMEA led with 7.7% growth despite geopolitical challenges; Americas rebounded strongly in Q2 after a soft Q1; Asia Pacific improved outside of a rebasing effect in China.
Bolt-on acquisitions (Finja and the pending Akkim deal) are already contributing to growth and synergy potential.

Silicon Motion Technology Corporation

SIMO Q2 2026

Reported: 2026-08-01

Silicon Motion’s shares surged 20.9% following Q2 2026 results as multiple revenue segments notably outperformed expectations, driven by significant market share gains and successful product ramps across embedded and SSD controller businesses.

Key takeaways

Q2 revenue reached a record $451 million with gross margin above 50%, underpinned by growth across all core markets.
Embedded eMMC & UFS segment grew strongly despite overall smartphone unit declines, benefiting from market share gains and ASP improvements due to a mix shift toward newer UFS controllers.
Edge SSD controllers delivered 40% to 45% year-over-year growth, supported by early ramp of PCIe 5 4-channel controllers, although PCIe 4 to PCIe 5 transition remains slower than initially anticipated.
Initial commercial ramp of MonTitan enterprise lead products and robust growth in automotive and enterprise boot drive solutions contributed to diversification and revenue expansion.
Management anticipates record revenue growth for full-year 2026, driven by continued share gains and new product transitions despite ongoing NAND supply challenges.

Sundial Growers Inc.

SNDL Q2 2026

Reported: 2026-08-01

SNDL shares dropped 11.1% after disappointing investors with continued revenue declines, margin compression, and higher production ramp-up costs that pressured profitability across liquor and cannabis segments.

Key takeaways

Net revenue declined 3.7% year-over-year to $235.8 million, led by a $7.2 million drop in liquor retail and $3.6 million in cannabis operations.
Gross profit fell 16.6% to $56.3 million, with margins down 3.7 percentage points due to pressures in cannabis operations and liquor retail.
Adjusted operating loss widened to $7 million, driven primarily by lower gross profit, new production ramp-up costs, and a $2.3 million SunStream valuation reduction.
Free cash flow improved modestly by $1.2 million year-over-year to negative $6.7 million, despite seasonal headwinds and increased cash in transit.
The company accelerated share repurchases, reducing shares outstanding by about 7% since late 2024, while maintaining a strong balance sheet with no debt and $183.2 million in unrestricted cash.

Sollensys Corp.

SOLS Q2 2026

Reported: 2026-08-01

Solstice Advanced Materials delivered better-than-expected top and bottom line results, with revenue and adjusted EBITDA surpassing guidance, driving an 8.1% stock rally. Investors responded positively to strong demand momentum across key segments and raised full-year guidance.

Key takeaways

Q2 net sales grew 11% year-over-year to $1.148 billion, exceeding the high end of guidance.
Adjusted EBITDA rose 2% year-over-year to $290 million, also above guidance, with margin stable at 25.3%.
Growth driven by strong demand in Refrigerants & Applied Solutions (notably HFO refrigerants and data center orders) and Electronic & Specialty Materials (semiconductor applications).
GAAP net income reached $119 million, up from $97 million last year; adjusted EPS was $0.88.
Free cash flow for H1 2026 was $248 million despite increased growth CapEx to support strategic investments and expansion projects.

Spok Holdings, Inc.

SPOK Q2 2026

Reported: 2026-08-01

Spok's shares declined 1.3% following Q2 results as investors digested solid operational execution but cautious outlook signals and mixed growth metrics tempered enthusiasm. The modest share decline indicates the market is cautious about near-term growth trajectory and outlook clarity despite operational improvements.

Key takeaways

Bookings for software operations surged nearly 92% sequentially, reflecting strong sales momentum in higher-margin segments.
Wireless average revenue per unit remained stable year-over-year, sustaining a key revenue contributor despite a slight (<2%) decline in units in service.
Adjusted EBITDA reached record levels, supported by a nearly 8% reduction in operating expenses versus prior year, driven by strategic realignment and efficiency initiatives including AI adoption.
Product development investment grew about 10% year-over-year, signaling continued focus on innovation despite expense controls.
The company closed a significant asset sale recently to bolster its capital allocation strategy but provided no material updates on full-year guidance visible in the transcript.

Seagate Technology plc

STX Q4 2026

Reported: 2026-08-01

Shares fell 6.4% as investors reacted negatively to signs of a cautious outlook despite reported strength, with concerns likely centered on margin and growth execution risks amid cautious forward commentary not aligned with market expectations.

Key takeaways

Revenue and non-GAAP EPS reportedly beat internal expectations, but the stock’s decline suggests skepticism about sustainability or outlook.
Management highlighted expanding non-GAAP gross margins for the 13th consecutive quarter and strong free cash flow margins reaching 31%, totaling over $1.1 billion in the quarter.
Fiscal 2026 saw revenue growth of 34%, driven by cloud demand and AI-enhanced applications, with mid-20% exabyte growth targeted via HAMR-based Mozaic platform investments.
Data center demand represents about 90% of exabyte shipments, with long-term supply agreements extending into 2028 and discussions to lengthen planning horizons through 2029.
Although management expressed confidence in demand durability and margin expansion, the stock’s drop signals investor doubts about growth pacing, margin sustainability, or the overall outlook.

Schneider Electric S.E.

SU.PA Q2 2026

Reported: 2026-08-01

The stock gained 12.8% as Schneider Electric delivered strong organic growth and margin expansion that outpaced market expectations, supported by solid demand across key segments and a promising strategic acquisition to enhance digital capabilities.

Key takeaways

Q2 organic revenue growth of 17%, with Energy Management growing 18% and Industrial Automation up 11%.
H1 organic growth stood at 14%, reflecting broad-based strength across buildings, industry, data center, and infrastructure segments.
Adjusted EBITA margin improved by 120 basis points in H1, slightly better than prior guidance of neutral to slightly negative margin change.
Free cash flow reached a high level of EUR 1.6 billion, sustaining strong cash generation.
The pending acquisition of Cognite is positioned to accelerate Schneider’s digital transformation and AI capabilities, complementing the data-driven strategy outlined earlier.

Stanley Black & Decker, Inc.

SWK Q2 2026

Reported: 2026-08-01

Stanley Black & Decker's shares rose modestly by 1.4% following a quarter marked by stable revenue and margin improvement, driven primarily by U.S. volume strength and tariff refund benefits; however, modest growth and some regional softness suggest a mixed outlook.

Key takeaways

Total revenue was flat year-over-year, with organic growth of 3% driven by volume gains in U.S. Tools & Outdoor across retail and commercial-industrial channels.
Adjusted gross margin improved 620 basis points year-over-year to 33.7%, aided by productivity, product mix, and approximately 250 basis points from tariff refunds.
Tools & Outdoor segment organic revenue grew 3%, powered by an 8% increase in power tools, offset partially by a 7% decline in outdoor due to weather-related demand softness.
Engineered Fastening revenue fell 18% due to the divestiture of Aerospace Fasteners; organically, it grew 3% with margin expansion of 220 basis points.
Management deployed proceeds from the divestiture and operating cash flow to reduce debt by $1.7 billion and repurchased $250 million in shares, supporting capital allocation priorities.

SunCoke Energy, Inc.

SXC Q2 2026

Reported: 2026-08-01

Suncoke Energy’s shares dropped 9.4% following earnings as investors reacted negatively to weaker-than-expected sales volumes in the domestic coke segment and ongoing cash flow timing issues, despite raised guidance and margin improvements.

Key takeaways

Domestic coke sales volumes declined to 878,000 tons from 943,000 tons year-over-year, largely due to the Haverhill One shutdown.
Consolidated adjusted EBITDA rose to $69.6 million, boosted by the Phoenix acquisition and higher terminal handling volumes.
Industrial services segment adjusted EBITDA surged to $34.4 million, more than quadrupling from the prior year period.
Operating cash flow was negative $27.2 million, impacted by the delayed collection of $65 million in cash receipts expected after quarter-end.
Full year guidance for consolidated adjusted EBITDA was raised to a range of $250 to $265 million, and operating cash flow guidance was increased to $240 to $260 million, but concerns remain around underlying sales volume trends and cash flow timing.

Stryker Corporation

SYK Q2 2026

Reported: 2026-08-01

Stryker's stock fell 7.5% following the earnings release as investors reacted negatively to meaningful supply disruptions in the peripheral vascular business that caused significant lost sales and pressured margins despite solid overall organic growth.

Key takeaways

Reported 9% organic sales growth driven by strong performances in MedSurg, Neurotechnology, and Orthopedics.
Supply chain issues in the peripheral vascular segment led to a considerable backlog and lost sales; management expects backorders to normalize by end of Q3.
Adjusted EPS grew 17.9%, benefiting from operational execution and tariff-related cost benefits, though offset in part by margin pressure in disrupted segments.
US organic growth was 9% with double-digit growth in medical, trauma extremities, and endoscopy businesses; Instruments grew 8.4% in the US.
International organic growth stood at 8.9%, supported by strong demand in diverse markets including Australia, Germany, and Japan.

Telecom Italia S.p.A.

TIT.MI Q2 2026

Reported: 2026-08-01

TIM’s Q2 results were broadly in line with expectations, reflected by a flat stock reaction. While underlying operational metrics showed signs of improvement, the temporary MVNO transition continued to weigh on reported numbers, resulting in little market movement.

Key takeaways

Group revenues increased 2.0% year-over-year to EUR 6.8 billion; excluding the MVNO transition, revenue growth was 3.3%.
EBITDA after lease rose 1.2% reported, and 6.3% on an underlying basis excluding MVNO impact, indicating improving operating leverage.
Domestic market revenues were stable; adjusted for MVNO effects, they grew about 2%, with EBITDA after lease up 7.1%.
Brazil segment delivered strong growth: revenues up 6%, EBITDA after lease up 5.5%, maintaining its role as a key growth driver.
Capital discipline continued with EUR 0.9 billion CapEx (12.6% of revenues), EUR 0.7 billion equity free cash flow, and a stable leverage ratio of 1.94x.

Teekay Tankers Ltd.

TNK Q2 2026

Reported: 2026-08-01

Shares of Teekay Tankers inched up modestly by 1.5% following second quarter results marked by a record spot tanker rate environment and solid free cash flow generation, though the market reaction indicates tempered enthusiasm given emerging geopolitical risks and some softness in Aframax rates.

Key takeaways

Reported GAAP net income reached $226 million ($6.49 per share), with adjusted net income at $194 million ($5.56 per share), a 50% increase from the prior quarter and the highest quarterly adjusted earnings in company history.
Average spot tanker rates hit all-time highs, with Suezmax vessels earning $109,000 per day and Aframax LR2 vessels $74,100 per day during the quarter.
Generated approximately $200 million in free cash flow from operations, boosting cash reserves to over $1.2 billion while maintaining a debt-free balance sheet.
Executed fleet renewal strategy by acquiring two new Korean Suezmax vessels for $190 million and selling older tonnage, including a 2009 Suezmax for a $32.3 million gain and a VLCC vessel recently sold for $84.5 million with an expected $23 million gain next quarter.
Geopolitical tensions, particularly in the Strait of Hormuz and Red Sea, are causing volatility in trade routes and tanker demand; some softening in Aframax spot rates mid-quarter due to Atlantic tonnage buildup dampened upside, although rates rebounded in July.

Tourmaline Oil Corp.

TOU.TO Q2 2026

Reported: 2026-08-01

Tourmaline’s stock fell 4% following the quarter as investors reacted negatively to the cautious production execution and a deliberate deferral of activity amid low natural gas prices, signaling concerns about operational deceleration and near-term growth visibility.

Key takeaways

Q2 production averaged 594,000 BOEs/day, slightly below guidance (595,000–605,000), due to intentional activity curtailment and increased natural gas storage injections in response to weak prices.
Full-year production guidance remains at 620,000–640,000 BOEs/day, with a targeted exit rate of 660,000 BOEs/day, but actual growth may be more limited given the operational pause.
Capital budget stands at $2.55 billion for 2026 after a $350 million reduction earlier in the year; the company is scheduling a one-year pause between Phase 1 and Phase 2 of the BC Montney build-out to preserve free cash flow and reassess market conditions.
Operating expenses per BOE decreased 10% year-over-year to $4.59, signaling ongoing cost discipline despite weaker pricing.
Strategic infrastructure developments, including expanded LPG export capacity and natural gas storage, aim to improve margins but will take time to materially impact cash flow.

Piraeus Financial Holdings S.A.

TPEIR.AT Q2 2026

Reported: 2026-08-01

Piraeus Bank’s shares rose modestly by 1.1% following its first half 2026 results, reflecting steady performance with no clear catalyst to materially move the stock. The bank showed ongoing loan growth and improving profitability but offered limited upside beyond solid execution.

Key takeaways

Reported net profit of EUR 617 million (EPS EUR 0.47) and return on average tangible book value of 16%, slightly above 2026 targets.
Loan book expanded 9% YoY to EUR 39 billion, with EUR 1.8 billion net credit growth in the first half and broad-based sector support.
Revenue diversification progressing, with service fees up 42% YoY to EUR 462 million, representing 32% of total revenues, driven largely by investment, insurance, and financing fees.
Net interest income improved to EUR 990 million, margin at 2.2%, supported by volume growth amid mild spread compression.
Asset quality remains stable with NPE ratio at 2.2%, cost of risk low at 45 basis points, and capital position strengthening (CET1 ratio 12.8%).

TriMas Corporation

TRS Q2 2026

Reported: 2026-08-01

TriMas shares rose modestly by 1.5% following Q2 results as the market remains cautious amid ongoing execution on strategic initiatives and operational improvements, with no clear catalyst to drive a stronger move.

Key takeaways

Continued implementation of cost-reduction actions totaling $10.5 million YTD and $16 million annually is helping to improve profitability.
Leadership additions in Packaging sales, marketing, and global operations aim to support commercial execution and operational excellence.
Integration of legacy packaging brands under one global TriMas Packaging identity is expected to enhance customer alignment and simplify the customer experience.
Share repurchases exceeding 5 million shares since November have reduced share count, reflecting a commitment to capital return.
Management remains disciplined and patient regarding deployment of Aerospace divestiture proceeds, maintaining financial flexibility.

Tyler Technologies, Inc.

TYL Q2 2026

Reported: 2026-08-01

Tyler Technologies shares fell 7.2% after earnings as investors reacted negatively to a noticeable deceleration in organic revenue growth and lower-than-expected margin performance, despite management’s upbeat commentary on bookings and strategic initiatives.

Key takeaways

Organic revenue growth trailed overall growth by approximately 2 percentage points, signaling underlying softness in the core business.
Bookings included about $11 million contributed from the recent acquisition, indicating limited organic bookings growth momentum.
Margins were weighed down by a couple of one-time items this quarter, with margin expansion of roughly 100 basis points expected for the full year but muted near term.
Management highlighted continued confidence in M&A, AI strategy, and market demand but did not provide reassuring updates on stronger immediate financial performance.
Free cash flow was a record for the second quarter, but the cautious tone on growth and reliance on acquisitions temper optimism.

CVR Partners, LP

UAN Q2 2026

Reported: 2026-08-01

CVR Partners shares rose 5.2% following Q2 results driven by higher-than-expected prices for UAN and ammonia amid constrained global nitrogen supplies. Elevated prices and strong operational uptime offset slightly lower volumes and rising costs.

Key takeaways

Net sales reached $202 million with EBITDA of $107 million, supported by a 24% increase in UAN prices and 33% increase in ammonia prices year-over-year.
Ammonia plant utilization was near full capacity at 99%, while volumes sold were slightly down due to an earlier planting season and softening demand late in the quarter.
Direct operating expenses rose by approximately $4 million relative to Q2 2025, driven by increased repair, maintenance, catalyst, and electricity costs.
The board declared a distribution of $6.08 per common unit, supported by $64 million of cash available for distribution after $43 million net cash needs.
Looking ahead, Q3 ammonia utilization will decline to 75-80% due to a planned turnaround, with associated incremental turnaround expenses of $30-35 million expected to weigh on operating efficiency.

Unisys Corporation

UIS Q2 2026

Reported: 2026-08-01

Unisys shares plunged 17.1% following the earnings release as investors were clearly disappointed by ongoing revenue decline and cautious outlook signals, despite some pockets of growth in Technology Solutions and Services and new business signings.

Key takeaways

Revenue declined 2% year-over-year, reflecting underlying demand challenges despite a 2% growth in Technology Solutions and Services (excluding ClearPath).
New business total contract value (TCV) rose sharply, up 57% year-over-year and 22% sequentially, driven largely by project work with existing clients.
Gross margin in Technology Solutions and Services improved by 170 basis points, benefiting from investments in technology and higher-value solutions.
Revenue headwinds persist, with ClearPath and legacy segments not detailed as performing well, suggesting pressure outside of TS&S.
Management highlighted ongoing investments in AI-infused solutions for long-term value, but immediate financial results and guidance likely fell short of market expectations.

Unibail-Rodamco-Westfield SE

URW.PA Q2 2026

Reported: 2026-08-01

Unibail-Rodamco-Westfield reported H1 2026 results that were largely in line with expectations, reflected in a flat market reaction of 0.0%. Despite solid operational metrics and active portfolio management, the lack of a clear catalyst limited investor enthusiasm.

Key takeaways

Like-for-like EBITDA grew above 5%, driven by sustained leasing momentum and increasing MGR uplifts (up 14% on long-term leases).
Group occupancy improved, with vacancy down 80 basis points to just over 4%, the lowest since 2017.
Tenant sales and footfall showed year-on-year growth, with double-digit sales increases at flagship locations like Westfield London and Westfield Centro.
Capital recycling completed with EUR 2.2 billion of disposals and disciplined reinvestment into value-accretive acquisitions and developments in the U.S.
Portfolio revaluation contributed positively, improving LTV by 90 basis points; Moody’s upgraded the outlook to positive given refinancing and financial management.

V.F. Corporation

VFC Q1 2027

Reported: 2026-08-01

VF Corporation shares declined sharply by 18% following the quarter as investors were clearly disappointed by a cautious outlook and signs of deceleration embedded in the commentary, despite efforts to reposition the company through leadership changes.

Key takeaways

CFO Paul Vogel announced his departure, with COO Abhishek Dalmia assuming a dual CFO/COO role, signaling a significant leadership transition during a critical transformation phase.
The company emphasized ongoing transformation initiatives focused on cost efficiency, technology, and operational improvements, but offered limited concrete progress metrics for the quarter.
Management highlighted past achievements such as margin expansion and leverage reduction but did not address near-term growth acceleration or improved guidance.
Comments underscored a cautious outlook, centering on disciplined capital deployment and balancing growth with profitability, implying investors may be bracing for slower momentum ahead.
No specific financial results or guidance revisions were detailed in this excerpt, suggesting uncertainty remains a key investor concern.

VICI Properties Inc.

VICI Q2 2026

Reported: 2026-08-01

VICI Properties shares declined 2.9% following Q2 2026 results as investors appeared cautious despite management’s growth initiatives, likely weighed down by modest near-term guidance and limited tangible progress on key financial metrics.

Key takeaways

Management highlighted a new strategic partnership with Club Med, marked by a $75 million investment at St. Croix, positioning for longer-term experiential resort growth.
The acquisition size is notable within the typically smaller net lease asset space but does not immediately drive significant earnings uplift.
There was no clear articulation of improved guidance or margin expansion in the prepared remarks, indicating steady but unspectacular financial performance.
The cautious market reaction suggests investors remain unconvinced about the near-term trajectory despite the promise of future growth via new relationships.

Veolia Environnement S.A.

VIE.PA Q2 2026

Reported: 2026-08-01

Veolia’s shares declined 1.9% following results that delivered modest growth amid higher costs and a cautious outlook on margin pressure. While EBITDA margins expanded and net income rose, investors likely weighed rising fuel and chemical prices alongside temporary margin compression.

Key takeaways

Revenue rose 1.5% to €22.2 billion, supported by growth in Municipal Water (+4.1% revenue) and Solid Waste segments.
EBITDA increased 5% at constant scope and FX, driving margin expansion of 70 basis points to 16%, reflecting operational efficiencies and international diversification.
Current net income grew 10.4%, consistent with previous guidance, leading the company to raise full-year net income growth guidance to at least 8%, including Clean Earth.
The geopolitical environment, notably the Middle East conflict, caused higher fuel and chemical costs, resulting in temporary margin pressure despite indexation protections.
Strong cash flow management improved net free cash flow by €164 million, and leverage remains controlled just above 3x despite the Clean Earth acquisition.

Valero Energy Corporation

VLO Q2 2026

Reported: 2026-08-01

Valero’s second-quarter results outpaced expectations, driving a 3.8% stock gain as solid operational execution across refining, renewable diesel, and ethanol segments translated into robust profitability and cash generation.

Key takeaways

Net income attributable to Valero was $3.7 billion ($12.62 per share), a substantial increase from $714 million ($2.28 per share) in Q2 2025.
Refining operating income reached $4.5 billion on 3 million barrels per day throughput, with cash operating expenses at $4.70 per barrel.
Renewable Diesel segment swung to $717 million operating income from a $79 million loss a year ago, with sales volumes averaging 3.8 million gallons per day.
Ethanol operating income rose to $318 million on 4.7 million gallons per day production.
The balance sheet strengthened, with cash reserves building by $2.1 billion to $7.9 billion and a low net debt-to-capitalization ratio of 11%.

Ventas, Inc.

VTR Q2 2026

Reported: 2026-08-01

Ventas shares dropped 4.3% following the quarter as investor enthusiasm waned despite strong operational performance, likely due to a cautious outlook and margin pressures highlighted in the call.

Key takeaways

Same-store NOI growth remained strong at 10% company-wide and 18% in U.S. senior housing (SHOP), with occupancy up 360 basis points year-over-year.
Second quarter FFO per share grew 9% year-over-year to $0.97, supporting revised full-year normalized FFO guidance raised to $3.85–$3.90.
Investment activity ramped significantly, with 2026 investment expectations increased to $4.5 billion from $3 billion, focusing on senior housing acquisitions.
Operating expenses grew 5%, leading to a modest margin expansion of 210 basis points and incremental margin flow-through of 55%, indicating some cost pressure amidst revenue growth.
Management signaled continued disposition of nonstrategic assets and noted that the competitive landscape and balanced supply/demand may temper near-term growth, contributing to investor caution.

Whitecap Resources Inc.

WCP.TO Q2 2026

Reported: 2026-08-01

Shares rose 3.2% as Whitecap’s production growth and cost reductions came in ahead of internal forecasts, lifting margins and free cash flow despite a cautious outlook on natural gas pricing and capital spending.

Key takeaways

Second quarter production averaged 38,894 BOE/d, exceeding the internal forecast by approximately 8,000 BOE/d, driven by strong performance at Kaybob and Central Alberta.
Raised 2026 production guidance by 5,000 BOE/d to 385,000 BOE/d, representing a total increase of 3% from the original budget.
Operating costs fell 13% year-over-year to $11.88 per BOE, prompting a downward revision of full-year operating cost forecast by $0.50 per BOE to $12.00 at midpoint.
Funds flow reached a record $1.4 billion ($1.11 per share), with free funds flow of $925 million used for significant net debt reduction of $900 million to $2.5 billion.
Realized crude oil and condensate prices benefited from a supply disruption in the Middle East, with liquids commanding premiums to WTI; natural gas prices remained challenged with AECO averaging $1.63/Mcf.

Worldline SA

WLN.PA Q2 2026

Reported: 2026-08-01

Worldline’s shares rose sharply by 17.8% as Merchant Services outperformed with accelerating growth and margin improvement, while key strategic initiatives demonstrated tangible progress, alleviating investor concerns about the ongoing turnaround.

Key takeaways

Merchant Services, representing 80% of external revenue, showed high-single-digit growth in Q2 with stronger customer satisfaction and solid performance across multiple regions, including Greece, Nordics, and Germany.
Adjusted EBITDA improved to €294 million with a margin increase at net revenue level for the first time since H1 2023, reflecting early benefits from transformation efforts and disciplined cost control.
Financial Services continued to face headwinds from planned contract terminations and longer sales cycles but secured significant new contracts, including an outsourcing deal with ICS (ABN AMRO) and participation in the ECB digital euro pilot.
Balance sheet strength improved notably with net debt leverage reduced below 2x EBITDA following capital increases and M&A activity including MeTS and Cetrel acquisitions.
The North Star transformation program made steady progress with platform convergence advancing (5,000 merchants migrated), infrastructure simplification, and automation initiatives like Launchpad entering pilot phase targeting faster SMB onboarding.

Wave Life Sciences Ltd.

WVE Q2 2026

Reported: 2026-08-01

Shares dropped 5.2% following earnings, reflecting investor disappointment primarily driven by cautious outlook and limited new financial guidance amid ongoing clinical developments.

Key takeaways

Delivered multiple positive clinical data sets in RNAi and RNA editing pipelines, notably WVE-007 for obesity and WVE-006 for AATD.
Phase IIa trial of WVE-007 underway, targeting higher-risk obesity patients with comorbidities; additional combo and maintenance trials planned.
Received FDA acceptance for Phase IIa INLIGHT trial amendment; meeting with FDA on accelerated approval pathway for WVE-006 expected late summer.
Advancing WVE-008 targeting PNPLA3 liver disease with planned CTA filing later this year; RNA editing approach uniquely positioned given silencing limitations.
No new financial guidance or updates were provided, leaving questions on near-term commercial visibility and growth, which likely weighed on shares.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.